A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 6,366,901 shares of DNA stock, worth $47.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,366,901
Holding current value
$47.2 Million
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$0.28 - $1.16 $1.78 Million - $7.39 Million
6,366,901 New
6,366,901 $2.1 Million
Q2 2022

Aug 12, 2022

BUY
$2.2 - $4.2 $3.92 Million - $7.48 Million
1,782,100 Added 131.1%
3,141,400 $7.48 Million
Q1 2022

May 13, 2022

BUY
$2.83 - $8.69 $3.85 Million - $11.8 Million
1,359,300 New
1,359,300 $5.48 Million

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $9.54B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.